These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 25897952)

  • 1. Modulation of the disordered conformational ensembles of the p53 transactivation domain by cancer-associated mutations.
    Ganguly D; Chen J
    PLoS Comput Biol; 2015 Apr; 11(4):e1004247. PubMed ID: 25897952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of p53 Transactivation Domain Conformations by Ligand Binding and Cancer-Associated Mutations.
    Liu X; Chen J
    Pac Symp Biocomput; 2020; 25():195-206. PubMed ID: 31797597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual Structures and Transient Long-Range Interactions of p53 Transactivation Domain: Assessment of Explicit Solvent Protein Force Fields.
    Liu X; Chen J
    J Chem Theory Comput; 2019 Aug; 15(8):4708-4720. PubMed ID: 31241933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-Associated Mutations Perturb the Disordered Ensemble and Interactions of the Intrinsically Disordered p53 Transactivation Domain.
    Schrag LG; Liu X; Thevarajan I; Prakash O; Zolkiewski M; Chen J
    J Mol Biol; 2021 Jul; 433(15):167048. PubMed ID: 33984364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation Regulates the Bound Structure of an Intrinsically Disordered Protein: The p53-TAZ2 Case.
    Ithuralde RE; Turjanski AG
    PLoS One; 2016; 11(1):e0144284. PubMed ID: 26742101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward Accurate Coarse-Grained Simulations of Disordered Proteins and Their Dynamic Interactions.
    Zhang Y; Liu X; Chen J
    J Chem Inf Model; 2022 Sep; 62(18):4523-4536. PubMed ID: 36083825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leucine-rich hydrophobic clusters promote folding of the N-terminus of the intrinsically disordered transactivation domain of p53.
    Espinoza-Fonseca LM
    FEBS Lett; 2009 Feb; 583(3):556-60. PubMed ID: 19162020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atomistic details of the disordered states of KID and pKID. Implications in coupled binding and folding.
    Ganguly D; Chen J
    J Am Chem Soc; 2009 Apr; 131(14):5214-23. PubMed ID: 19278259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electronic Polarization at the Interface between the p53 Transactivation Domain and Two Binding Partners.
    Corrigan AN; Lemkul JA
    J Phys Chem B; 2022 Jul; 126(26):4814-4827. PubMed ID: 35749260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the K24N mutation on the transactivation domain of p53 and its binding to murine double-minute clone 2.
    Zhan YA; Wu H; Powell AT; Daughdrill GW; Ytreberg FM
    Proteins; 2013 Oct; 81(10):1738-47. PubMed ID: 23609977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of p53 N-terminal transactivation domain 2 conformation ensemble and kinetics by phosphorylation.
    Zhao L; Ouyang Y; Li Q; Zhang Z
    J Biomol Struct Dyn; 2020 Jun; 38(9):2613-2623. PubMed ID: 31248328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replica exchange with guided annealing for accelerated sampling of disordered protein conformations.
    Zhang W; Chen J
    J Comput Chem; 2014 Sep; 35(23):1682-9. PubMed ID: 24995857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended string binding mode of the phosphorylated transactivation domain of tumor suppressor p53.
    Okuda M; Nishimura Y
    J Am Chem Soc; 2014 Oct; 136(40):14143-52. PubMed ID: 25216154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative prediction of ensemble dynamics, shapes and contact propensities of intrinsically disordered proteins.
    Yu L; Brüschweiler R
    PLoS Comput Biol; 2022 Sep; 18(9):e1010036. PubMed ID: 36084124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transient manifold structure of the p53 extreme C-terminal domain: insight into disorder, recognition, and binding promiscuity by molecular dynamics simulations.
    Fadda E; Nixon MG
    Phys Chem Chem Phys; 2017 Aug; 19(32):21287-21296. PubMed ID: 28597880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiscale ensemble modeling of intrinsically disordered proteins: p53 N-terminal domain.
    Terakawa T; Takada S
    Biophys J; 2011 Sep; 101(6):1450-8. PubMed ID: 21943426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
    Inga A; Resnick MA
    Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual structures, conformational fluctuations, and electrostatic interactions in the synergistic folding of two intrinsically disordered proteins.
    Zhang W; Ganguly D; Chen J
    PLoS Comput Biol; 2012 Jan; 8(1):e1002353. PubMed ID: 22253588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural ensemble of an intrinsically disordered polypeptide.
    Mittal J; Yoo TH; Georgiou G; Truskett TM
    J Phys Chem B; 2013 Jan; 117(1):118-24. PubMed ID: 23205890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.